Vitrolife AB (publ)
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| VITR.ST | BIO | GTN0.F | XVIVO.ST | QLIFE.ST | CEVI.ST | |
|---|---|---|---|---|---|---|
| Market cap | 16.15B | 10.16B | 7.01B | 6.37B | 26.07M | 4.83B |
| P/E (TTM) | — | 48.2 | 26.3 | 49.4 | — | 35.0 |
| Forward P/E | 25.3 | 39.0 | — | 34.2 | -5.0 | 24.6 |
| Price/book | 2.0 | 1.4 | 0.2 | 2.8 | 9.8 | 5.2 |
| Dividend yield | 0.93% | — | 1.80% | — | — | 1.38% |
| 1-year change | −17.77% | +23.96% | +22.84% | +10.74% | −52.43% | +24.87% |
| Today | +3.31% | +1.35% | +3.31% | +0.60% | −9.61% | +1.35% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All VITR.ST news ›Nomination committee of Vitrolife AB (publ) for the Annual General Meeting 2027
In accordance with the Nomination Committee Charter adopted at the Annual General Meeting 2026, the members who, together with the Chair of the Board, constitute the Nomination Committee in preparation of the Annual General Meeting 2027…
Vitrolife AB (publ) 2026 Q3 - Results - Earnings Call Presentation
2026-10-23. The following slide deck was published by Vitrolife AB (publ) in conjunction with their 2026 Q3 earnings call. The following slide deck was published by Vitrolife AB (publ) in conjunction with their 2026 Q3 earnings call.
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- seekingalpha.com2
- tradingview.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.